Vimian acquires UK allergy business

March 16, 2022

The Vimian Group is a global and fast-growing group of innovation-driven companies that share a passion for making a positive impact through improving animal health.

Vimian Group’s Specialty Pharma segment Nextmune has acquired the veterinary allergy division, Avacta Animal Health, from AvactaGroup plc. Avacta Animal Health provides veterinary allergy diagnostic solutions through its laboratory in Wetherby (UK) and re-sells Nextmune’s immunotherapy products to veterinary clinics across the UK. The business division also provides testing kits to veterinary laboratories in other European countries. The acquisition is a carve-out from AvactaGroup plc, a UK-based company focused on diagnostic solutions for human health.

The business had revenues of GBP 1.6 million in 2021.

Read more here.

Recent news

Vimian resolves on a rights issue of up to approx…

The Board of Directors of Vimian Group AB has based on the authorisation from the Annual General Meeting on 2 June 2023, resolved on a rights issue of up to approximately SEK 1,633 million. The purpose of the Rights Issue

Read more

David von Laskowski, Greenfood’s CEO, is awarde…

On the 22 of February, the winners of the “CEO of the Year” award were announced at Kistamässan in Stockholm. The winner in the Large-Cap category was David von Laskowski, Picadeli & Greenfood Group. “CEO of the Year” has been

Read more

Odevo strengthens its UK footprint as Vegner Grou…

Vegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients,  bringing further

Read more